Clinical trials
Phase 1 Adenocarcinoma, Bronchiolo-Alveolar trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2008 | 1 |
| 2009 | 2 |
| 2014 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
| Terminated | 2 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 3 |
| Memorial Sloan Kettering Cancer Center | 2 |
| University of Texas Southwestern Medical Center | 2 |
| Alliance for Clinical Trials in Oncology | 1 |
| Barbara Ann Karmanos Cancer Institute | 1 |
| Eastern Cooperative Oncology Group | 1 |
| Jonsson Comprehensive Cancer Center | 1 |
| Medical University of South Carolina | 1 |
| National Institutes of Health Clinical Center (CC) | 1 |
| Wake Forest University Health Sciences | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Adenocarcinoma, Bronchiolo-Alveolar | 14 |
| Carcinoma, Non-Small-Cell Lung | 14 |
| Adenocarcinoma of Lung | 11 |
| Lung Neoplasms | 11 |
| Neoplasm Metastasis | 3 |
| Small Cell Lung Carcinoma | 3 |
| Burkitt Lymphoma | 2 |
| Hodgkin Disease | 2 |
| Immunoblastic Lymphadenopathy | 2 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 2 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.